New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
09:17 EDTADMPAdamis Pharmaceuticals announces FDA acceptance of NDA for Epinephrine Injection
Adamis Pharmaceuticals announced that the FDA has accepted for review its New Drug Application, or NDA, for the product, Epinephrine Injection PFS, for the emergency treatment of allergic reactions including anaphylaxis.
News For ADMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
09:08 EDTADMPAdamis Pharmaceuticals announces positive results for Phase I PK study
Subscribe for More Information
February 24, 2015
09:13 EDTADMPAdamis announces pharmacokinetic study results for APC-1000
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use